Genomics: Harvard University

Total Score People Score Events Score
263 202 72
Date Event Presentation Speakers
November 7, 2016 Frontiers in Cancer Science 2016 LORENZ POELLINGER KEYNOTE TALK William G Kaelin
July 5, 2016 The 3rd Friends of Israel Urology Symposium (FOIU) The 3rd Friends of Israel Urology Symposium (FOIU) Venkatesh N Murthy
April 13, 2016 Genomics of Rare Disease: Beyond the Exome Parallel analysis of gene expression in thousands of individual cells using nanoliter droplets Steven McCarroll
January 24, 2016 10th PMWC 2016 Personalized Medicine World Conference TRACK 1 | Raghu Kalluri
April 10, 2015 Asian Oncology Summit 2015 Systemic therapy for cholangiocarcinoma: novel targets Andrew Zhu
Next generation of targeted therapy for NSCLC Pasi A Janne
Optimal management of metastatic hepatocellular carcinoma Andrew Zhu
September 17, 2014 Nature Genetics and the Wellcome Trust present: The Genomics of Common Diseases 2014 Nature Genetics and the Wellcome Trust present: The Genomics of Common Diseases 2014 Martha L Bulyk, David Altshuler, Lynda Chin
June 10, 2014 Clinical Genome Conference From Big Data to Network Medicine John Quackenbush
May 22, 2014 Drug Discovery Summit Drug Discovery Summit Jorge Plutzky, Alec Chapman
April 28, 2014 Companion Diagnostics: From Biomarker Identification to Market Entry Genomics Medicine Raju Kucherlapati
March 5, 2014 Targeted Anticancer Therapies Preclinical Models in the Development of Cancer Therapeutics Kwok-Kin Wong
February 17, 2014 Sao Paulo Advanced School in Oncogenesis and Translational Medicine (ESPCA) + Bioinformatics (Mini-course) Molecular-based classification of glioblastoma – Prof. Dr. Cameron Brennan Cameron W Brennan
January 30, 2014 Genitourinary Cancers Symposium General Session 3: Prostate Cancer- Tumor Board Audience Challenge (ARS) A. Oliver Sartor
General Session 5: Advances in Therapy for Urothelial Carcinoma Jonathan Rosenberg
January 6, 2014 AACR-IASLC Joint Conference on the Molecular Origins of Lung Cancer Concurrent Sessions 3-4 Kwok-Kin Wong
Plenary Session 4: EGFR Mutants in Lung Cancer: A 10-Year History Thomas J Lynch
Plenary Session 7: Advances in Molecular Targets and Novel Pathway-Based Therapy Bruce E. Johnson
November 14, 2013 2013 PQG Conference - Emerging Quantitative Issues in Disease Epigenetics Genome in 3D Leonid Mirny
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Systems Biological Approaches to Vaccination Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Ofer Levy
Poster Viewing Ofer Levy
Immunology of Vaccination in the Young and Elderly Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Ofer Levy
September 7, 2013 The Genomics of Common Diseases The Genomics of Common Diseases Heidi Rehm, Shaun Purcell
July 21, 2013 54th Annual Short Course on Medical and Experimental Mammalian Genetics C hromosome Struc ture and Function Jeanne Lawrence
Saturday, July 27 Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds Arkhat Abzhanov
Friday, August 2 Reawakening Fetal Hemogl o bin for Therapy: An Old Problem with New Prospects Stuart Orkin
May 31, 2013 ASCO Annual Meeting 2013 Optimizing the Role of Advanced Practice Professionals in Oncology Practice Lawrence N. Shulman
Hot Pathways for Targeted Therapy of B-Cell Malignancies James E. Bradner
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer Ian E. Krop
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer David Kwiatkowski
Cancer Stem Cells: A New and Better Target in Pediatric Oncology? Scott A. Armstrong, George Daley
Reaping the Rewards of the Cancer Genome Atlas Project Levi A Garraway
Improving Cancer Care through Health Information Technology: Ethics and Practicality Lawrence N. Shulman
Education Sessions Robert G Maki, Stephen T Sonis
Education Sessions Deborah Schrag
Education Sessions Tracy T Batchelor
Education Sessions Michael B. Atkins, Jennifer A. Ligibel
Educations Sessions Monica M. Bertagnolli
Education Sessions Bruce E. Johnson, Elizabeth R. Gerstner
May 28, 2013 NGS Translate In Vivo Dynamics of the Microbiota: Development of Computational Models for Time Series Analyses Lynn Bry
May 1, 2013 EMBO | EMBL Symposium: New Model Systems for Linking Evolution and Ecology Developmental mechanisms for morphological evolution: Insights from birds and lizards Arkhat Abzhanov
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
February 3, 2013 Neurogenesis (J7) Welcome and Keynote Address Li Huei Tsai
Model Systems Christopher Walsh
Stem Cell Niches in the Developing and Adult Brain Christopher Walsh
iPSC Modeling of Developmental and Degenerative Neurological Diseases (Joint) Li Huei Tsai
February 3, 2013 New Frontiers in Neurodegenerative Disease Research (J8) Genome Integrity, Chromatin Remodeling and Neurodegenerative Disorders Li Huei Tsai
iPSC Modeling of Developmental and Degenerative Neurological Diseases (Joint) Li Huei Tsai
September 13, 2012 International Society of Gastrointestinal Oncology Transarterial Embolic Therapy for Liver-Predominant NETs: Bland vs. Chemoembolization vs. Radioembolization David R Liu
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer Group B Van Transportation to GRB Training Lab | Workshop: (Group B) Pathology, Tissue Trimming, and Necropsy Paul Doty
Pathology and histopathology of normal and neoplastic tissue: an overview Paul Doty
EGFR Pathways and Cancer Pasi A Janne
Modeling the Ras Pathway in Cancer Karen Cichowski
Mouse Cancer Models for Targeting PI 3-K Lewis Cantley
Personalized medicine Raju Kucherlapati
Tumor Angiogenesis And Microenvironment Rakesh K Jain
Zebrafish Models to Dissect Human Cancer Pathways Thomas A. Look
July 15, 2012 53rd Annual Short Course on Medical and Experimental Mammalian Genetics Evening Lecture | Title TBD David Altshuler
Title TBD Paul Ridker
Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds Arkhat Abzhanov
March 25, 2012 ISA 2012 - XVI International Symposium on Atherosclerosis Healthy Drinking an Important Component of Healthy Eating Frank B. Hu
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Welcome and Opening Remarks Judy Garber
Epigenetics of hormone dependence Myles Brown
June 20, 2011 Changing Landscape of the Cancer Genome (F3) Somatic Genome Alterations in Human Lung Cancer Matthew Meyerson
GBM Lynda Chin
Characterizing the Prostate Cancer Genome Levi A Garraway
Talk Title to be Determined Richard Wilson
Protein Interactome Marc Vidal
May 8, 2011 Omics Meets Cell Biology (E1) Large-Scale Analyses of Signaling Networks Norbert Perrimon
March 27, 2011 Autophagy (D1) Workshop 2: Autophagy and Disease: A Clinical Point of View Ramnik J. Xavier
Homeostatic connection between the Unfolded Protein Response (UPR) and autophagy in neurodegeneration. C Hetz
Integrative Genomics Approaches to Gene Discovery in Autophagy and Disease Ramnik J. Xavier
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Genes that Regulate Migration and Invasion Joan S Brugge
Molecular characterization of circulating tumor cells Daniel A Haber
Stem Cells in Normal Lung and Lung Cancer Carla Bender Kim
Roundtable: Cancer Stem Cells in Metastasis: Insights and Controversies Daniel A Haber
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Primary Central Nervous System Lymphoma Tracy T Batchelor
Management of Autoimmune Issues in Chronic Lymphocytic Leukemia Jennifer R. Brown
Comment Jennifer R. Brown
CDK Inhibitors Noopur Raje
PI3K | Akt Pathway Inhibitors Jennifer R. Brown
BCR | Downstream Therapeutic Targets Jennifer R. Brown
Aggressive Lymphoid Malignancies (Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia, Burkitt Lymphoma) Daniel J. DeAngelo
Outlook for Management of Bone Disease in Multiple Myeloma Noopur Raje
Multiple Myeloma Noopur Raje
Acute Myeloid Leukemia | Myelodysplastic Syndromes Daniel J. DeAngelo
November 18, 2010 IV Congress of the International Society of Nutrigenetics/Nutrigenomics ISNN Modulation of inflamatory cytokines by omega-3 fatty acids Jing X Kang
Public health programs based on poblational omics studies Frank B. Hu
November 13, 2010 From Functional Genomics to Systems Biology Session II: Gene expression Job Dekker
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Seed and soil hypothesis revisited Rakesh K Jain
Keynote Address | Title to be announced Joan Brugge
Welcome Bruce R. Zetter
August 5, 2010 13th Annual Duke Cardiothoracic Update and TEE Review Course Panel Discussion Q/A Feroze Mahmood
TEE in the ICU: The Focused Basic Exam Feroze Mahmood
Workshop G: Porcine Heart Dissection Wet Lab Feroze Mahmood
Hemodynamics; What I Need to Know for the Exam! Feroze Mahmood
Case 2: Mitral Regurgitation Feroze Mahmood
July 11, 2010 Translational Cancer Medicine 2010 (USA) Drugging “undruggable” transcriptional targets Gregory L Verdine
Novel strategies for drug development in oncology D. Gary Gilliland
Comprehensive genomic approaches to identify cancer targets William C Hahn
Modeling drug sensitivity and resistance in human tumor-derived cell lines Jeffrey Settleman
Functionalizing the cancer genome Lynda Chin
Title to be announced Levi A Garraway
Altered nutrient requirements in cells with activated mTOR complex 1 John Blenis
Title to be announced Shyamala Maheswaran
Title to be announced George Daniel Demetri
June 20, 2010 Human Variation: Cause and Consequence Disease Genetics | Mark Daly Mark Daly
Phenotypic consequences of variation in human genome structure Steven McCarroll
June 12, 2010 Genetics 2010: Model Organisms to Human Biology Session 1: Personal Genomics David Altshuler
Keynote Address: Gary Ruvkun
Workshops: High-Throughput RNAi Screening in Model Systems used to Study Human Biology at Genome Scale Workshop Liz Perkins, Stephanie Mohr
Session 7: Stem cell: the genetics of commitment Anjana Rao, George Daley
Session 6: Modern approaches to pathogenesis and infectious disease John Mekalanos
Session 5: Neurogenetics: from synapses to senescence Li Huei Tsai, P Sklar
Session 8: Organismal architecture and developmental disabilities Matt Warman
May 19, 2010 Towards Personalized Cancer Medicine New Cancer Targets Emerging From Studies of the von Hippel-Lindau Tumor Suppressor Protein William G Kaelin
Functionalizing the Cancer Genome Lynda Chin
SESSION III: Oncogenomics and Tumor Profiling Lynda Chin
Target and Drug Discovery in Oncology: The Right Drug for the Right Patient D. Gary Gilliland
April 11, 2010 Molecular Targets for Control of Vector-Borne Diseases: Bridging Lab and Field Research (F2) * Multigene Families: Role in Immunity and Pathology | Big Horn B Peter R. Preiser
March 5, 2010 The Future of Genomic Medicine III Large-scale Cancer Clinical Genomics George Daniel Demetri
November 6, 2009 Translating Scientific Advances Into Clinical Care for Cancer Lung Cancer Thomas J. Lynch
September 21, 2009 Next-Generation Sequencing Data Analysis KEYNOTE PRESENTATION 1 John Quackenbush
September 21, 2009 Third Annual Exploring Next Generation Sequencing Targeted Sequencing of Human Genomes, Transcriptomes and Methylomes Jin Billy Li
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Michael Foley, Ph.D. Build-Couple-Pair Strategy for Diversity-Oriented Synthesis Yields a Unique Compound Collection for Probe Development and Drug Discovery Michael Foley
In Vivo Chemical Screening in Zebrafish Joanna Yeh
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) TBD Yu-Li Wang
Co-Chair :Track 2-8 Zhen Y. Jiang
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 Zhen Y. Jiang
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 Myriam Aouadi
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 Yu-Hua Tseng
Title: TBD : Track 4-4 Jing X. Kang
November 12, 2008 Third Annual Post-Approval Drug Safety Strategies: Best Practices to Mitigate Risks throughout the Product's Life Cycle Establishing Best Practices in Evaluating, Planning and Executing “Fit-for-Purpose” Benefit/Risk Management Programs for the 21st Century Bjorn Olsen
November 12, 2008 Concurrent Education and Social Issues Sessions I (1-4) SESSION 3 – Benefits and Risks: Assessing the Experience with Open Data Access Models for Genome-Wide Association Studies Challenges and vulnerabilities to participant protection presented by existing models for GWAS data sharing. Pearl O'rourke
October 21, 2008 RNAi for Screening Cancer Proliferation Gene Discovery Through Functional Genomics Stephen J Elledge
A Systems Biology Approach to Dissecting the Topology of the Insulin Signaling Network Norbert Perrimon
September 23, 2008 Integrative Data Analysis An Integrated Data Warehouse for Biomedical and Translational Research John Quackenbush
Analysis of Copy-Number Variants in Association Studies for Complex Traits Iuliana Ionita Laza
September 22, 2008 Genomics Tools Genome-Wide Profiling of the Estrogen Response in Breast Cancer Through a Cistrome Integrative Approach Mathieu Lupien
May 18, 2008 COMPUTATIONAL ASPECTS - BIOMOLECULAR NMR Metabolic Changes Due to Expression of Oncogenes Gerhard Wagner
April 27, 2008 Difficult to Express Proteins Dual-Promoter Lentiviral System allows Inducible Igor Kramnik
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Title to be announced William G Kaelin
Clinical Targeting and Inhibition of Tyrosine Kinases in GIST and Sarcomas: Lessons for Cancer Therapy and Future Directions George Daniel Demetri
RNAi, NON-CODING RNA, AND microRNA William C Hahn
Functional Genomics, Experimental Models, and Cancer William C Hahn
March 9, 2008 NEW ANTIBACTERIAL DISCOVERY & DEVELOPMENT Antibiotic interactions to discourage resistance development Roy Kishony
March 9, 2008 Biology OF Acute Respiratory Infection Population dynamics Marc Lipsitch
Scavenger receptors and innate immunity Lester Kobzik
March 4, 2008 Maintenance of Genome Stability Conference 2008 Session 5: DNA repair and genome stability (Chair: Jiri Lukas) Alan D Andrea
February 19, 2008 Cancer Genomics and Epigenomics High Throughput Sequencing of the Tumor Genome Matthew Meyerson
Chromatin Bradley E Bernstein
RNA and Functional Screening Milan G Chheda,
Epigenomics Kornelia Polyak
February 10, 2008 Plant Innate Immunity Signaling II Jen Sheen
Innate Immunity in Animals Frederick M. Ausubel
February 3, 2008 Biomarker Discovery, Validation and Applications Registration Test User
New Strategies for Biomarker Discovery and Use Mark S Boguski
Imaging Biomarkers 1 Mitchell Albert, Perry F Renshaw
Genomic Strategies Perry F Renshaw
February 3, 2008 GRC - Molecular Evolution Discussion Leader Norman Johnson
January 22, 2008 Ubiquitin and Cancer: From Molecular Targets and Mechanisms to the Clinic SESSION 1: ONCOGENIC SIGNALING I Alfred L. Goldberg
New Insights into Proteasome Function Alfred L. Goldberg
Proteasome Inhibition for the Treatment of Hematological Malignancies Kenneth C Anderson
Proteasome Inhibition to Treat Solid Malignancies James C. Cusack
January 7, 2008 Eicosanoids and Other Mediators of Chronic Inflammation (A1) Signaling Networks that Intersect with Eicosanoids Roy J. Soberman
Workshop 1 : Mechanisms of Chronic Inflammation Vineet Gupta, Akiko Maekawa
Eicosanoids, Chronic Inflammation and Malignant Transformation Monica M. Bertagnolli
Cellular and Molecular Organization of the 5-Lipoxygenase Pathway Roy J. Soberman, Yoshihide Kanaoka, Joshua A. Boyce, K. . Frank Austen
Workshop 2 : Eicosanoids in Immune Regulation Roy J. Soberman, Joshua A. Boyce, Chiara Carnini, Kip M. Connor
January 6, 2008 Structural Genomics and its Applications to Chemistry, Biology and Medicine Following Session is for Structural Biology (J1) Macromolecular Dynamics: Experiment and Theory Gerhard Wagner
Following Session is for Structural Biology (J1) Membrane Protein Structure James Jeiwen Chou
Pushing the Limits of Structural Biology II: Advances in Methodologies for Structure Determination (Joint) Gerhard Wagner
Proteomics and Protein Assemblies/Networks Alexander B. Sigalov
December 1, 2007 47TH American Socieity of Cell Biology Design Principles for Connecting the Genome to the World I Philips, C. Ajo-Franklin
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm Timothy J Mitchison
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. C. Zhang
*Single-Molecule Analysis Reveals the Distribution of Potential vs. Active DNA Replication Origins in Human Cells R. Lebofsky
Cell Matrix Interactions (Room 140A) Yu-Li Wang
Advances in Bone Cell Molecular Biology: Epigenetic Control Jane Lian, Gary S Stein
CLASPs Clutching Microtubule Networks (Room 209 B/C) David Van Vactor
At the Limits: Optical Methods for Single Molecules, Cells, and Organisms Jennifer Waters, Samara Rech-Peterson
High Performance Image Analysis and Photomanipulative Techniques for Jeffrey Nickerson
Building the Cell (Room 140B) L Mahadevan
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206) Peter K. Sorger
Public Service Award Presentation Matthew Michael
Primary Role for Centrosome Proteins in Cilia Formation and Cilia-associated Disorders B Delaval, L Covassin Barberis, N Lawson, Stephen J Doxsey
Cell-Type Variation in Responses to Anti-mitotic Drugs. C Loy, J Orth, C Shamu, M Tsui, V Yanamadala, Timothy J Mitchison
Fluorescence Correlation Spectroscopy Workshop Daniel Needham
Actin Disassembly by Whole-Filament Destabilization.v H Kueh, W M Brieher, Timothy J Mitchison
How Does Thrombospondin Induce CNS Synaptogenesis? J. T. Lawler
Identifying Matrix- and Growth Factor-induced Transcriptional Dichotomies by Stochastic Sampling. K A Janes, Joan Brugge
High-Tech Cell Biology Kendall Knight
DNA Damage Signaling Events Revealed by 4Pi Microscopy. Kendall Knight, Brian T Bennett
Novel Microscopy Methodology to Examine DNA Damage Signaling and Repair. Brian T Bennett
Heterochromatin Formation in Fission Yeast. M Huarte, Yang Shi
Anti-fi brotic Property of CTGF siRNA in the Liver via Targeted Delivery to Hepatic Stellate Cells. David Roger Brigstock, C Lawrencia
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism Jian Li
Myosin-activated Random Stress Fluctuations in the Actin Cytoskeleton David Weitz
Cytoplasmic Dynein Is a Better Navigator than Kinesin on Tau-decorated Microtubules. J. L. Ross
Determining the Molecular Architectures of Cellular Machines by Satisfaction of Spatial Restraints: The Nuclear Pore Complex. Adrian Salic
Posters Displayed:Monday Joan Brugge
Amaxa GmbH: Alan D Andrea
Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Tom A Rapoport, N L Sullivan, K Marquis
Maintenance of Polarity and Cell Shape in Vibrio cholerae Matthew K Waldor
Biochemical Characterization of Type III-secreted Bacterial Acetyltransferases J Orth
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 2: Proteomics, Genomics and Biomarker Discovery Gregory L Verdine
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies Rakesh K Jain
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) BRIDGING CLINICAL AND IT (09:30-15:30) Samuel (Sandy) Aronson, Heidi Rehm
BRIDGING CLINICAL AND IT: IT Support for the Clinical Use of Genetics and Genomics – Could the Infrastructure in Place Today Be Strengthened through Collaborations with Pharma IT Departments? (11:45-12:30) Samuel (Sandy) Aronson, Heidi Rehm
July 28, 2007 From Unfolded Proteins in the Endoplasmic Reticulum to Disease Carbohydrate-mediated protein maturation and quality control in the endoplasmic reticulum Dan N Hebert
A chemoproteomic approach implicates eukaryotic elongation factor 2 kinase in ER stress-induced cell death Marta Lipinski
ER Dysfunction in Obesity and Type 2 Diabetes Gokhan Hotamisligil,
July 7, 2007 CHROMATIN AND TRANSCRIPTION The chicken-and-egg relationship between transcription and chromatin structure Kevin Struhl
Analysis of the SAGA, Swi/Snf, and RSC complexes from S. pombe Fred Winston
Possible roles in silencing for piRNAs Bob Kingston
Complex interactions at the X-inactivation center Jeanie Lee
Histone H3-K56 acetylation is catalyzed by histone chaperonedependent complexes Paul Kaufman
June 9, 2007 Transport ATPases: Structure, Mechanisms, Genomics and Disease Na,K-ATPase as a signal transducer Sunney Xie
Cellular dynamics of FXYD proteins, regulators of Na,K-ATPase Elena Arystarkhova
Trafficking regulation of the V-ATPase in specialized cells of the kidney and epididymis” Sylvie Breton
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.